-
July 29, 2026
Private equity firm Apax Partners LLP will buy two businesses from Gerresheimer AG of Germany for €1.5 billion ($1.7 billion), the companies said Wednesday, as they seek expansion for the pharmaceutical packaging companies in the U.S.
-
July 28, 2026
To win a first-of-its-kind securities trial over short-swing profits, attorneys at Freshfields LLP knew they needed to find the right analogy to showcase their argument, even if it meant comparing the case to a craps table at a casino.
-
July 28, 2026
Meta and BlackRock are teaming up to develop a $14 billion, 1-gigawatt data center campus in El Paso, Texas, with guidance from Latham, Eversheds Sutherland, Kirkland and Milbank, the companies announced Tuesday.
-
July 28, 2026
Special purpose acquisition company Catalyst Acquisition Corp., which plans to target traditional and digital media businesses, hit the public markets Tuesday after raising $200 million in its initial public offering steered by three law firms.
-
July 28, 2026
The chief financial officer for an insurance company told a Florida jury Tuesday that a stock drop for Patriot National Inc. — which is suing Simpson Thacher & Bartlett LLP for malpractice for allegedly putting together a shoddy securities offering — dramatically affected his own business as well.
-
July 28, 2026
Apollo Global Management has agreed to invest $1.5 billion into an offshore energy fund managed by Singapore-based Keppel Ltd., with Latham & Watkins LLP advising Apollo-managed funds, Milbank LLP serving as investor counsel, and Clifford Chance LLP representing Keppel.
-
July 28, 2026
A Florida resident is set to plead guilty to his alleged role in a sweeping scheme to trade on insider information about impending acquisitions that was stolen from major law firms, according to a court filing Tuesday.
-
July 27, 2026
A former JPMorgan Chase employee filed a race discrimination and sexual harassment suit against the investment bank in Manhattan federal court Monday, on the heels of dropping a similar state court complaint that triggered an ongoing defamation case from his former boss.
-
July 27, 2026
A New Jersey state court on Monday entered a $25.4 million judgment against Cooley LLP after a jury found the multinational firm had committed malpractice in its representation of a biotech founder who said his own lawyers assisted in shoving him out of his company.
-
July 27, 2026
Defense and aerospace company ATI won escape from a proposed class action alleging it put retirees' benefits at risk by transferring approximately $1.5 billion of pension obligations to a private equity-backed insurance company, convincing a Pennsylvania federal court Monday that ex-workers hadn't sufficiently demonstrated standing to sue.
-
July 27, 2026
The Delaware Chancery Court has dismissed a stockholder challenge to Envestnet Inc.'s $4.5 billion take-private sale to Bain Capital affiliates, ruling that investors approved the deal through a fully informed vote and that the complaint failed to support claims that the company's independent directors or financial adviser Morgan Stanley acted improperly.
-
July 27, 2026
The managing partner of a New Hampshire-based private equity firm has pled guilty in New York federal court to multiple counts of fraud and money laundering in connection with a scheme that solicited over $50 million in investments for purported health and wellness companies.
-
July 27, 2026
A Delaware federal jury has awarded Yale University and Biohaven Therapeutics $4 million after finding that venture capital firm RA Capital Management GP breached a confidentiality agreement and, along with co-defendant Avilar Therapeutics, misappropriated a Yale-developed trade secret for designing protein-degrading drug molecules.
-
July 27, 2026
A Simpson Thacher & Bartlett LLP partner wrapped up her testimony Monday in a Florida state malpractice trial brought by the founder of Patriot National Inc., telling the jury that the founder was willing to forgo establishing a floor on the value of so-called Series B warrants, which he says contributed to the company's demise.
-
July 27, 2026
Wynnchurch Capital has agreed to buy aerospace materials maker Luxfer Holdings in a nearly $466 million deal, the companies announced Monday, with Kirkland & Ellis LLP advising Wynnchurch and Fried Frank Harris Shriver & Jacobson LLP advising Luxfer.
-
July 27, 2026
Paul Weiss Rifkind Wharton & Garrison LLP said Monday it has hired a former partner at Ropes & Gray LLP as a partner in its capital markets group within the firm's corporate department.
-
July 27, 2026
Freshfields LLP announced Monday that a prolific dealmaker has left White & Case to join its New York office as a partner in the mergers and acquisitions and corporate practice.
-
July 27, 2026
The Delaware Chancery Court last week tackled disputes involving restrictive covenants, corporate governance, trade secrets, real estate investments, receiverships, and books and records demands.
-
July 27, 2026
U.S. Department of Energy Reactor Pilot Program participant Antares announced Monday that it had raised $470 million in its Series C funding, which will allow the company to accelerate the commercialization of its nuclear power systems.
-
July 27, 2026
Expand Energy said Monday it will acquire privately held natural gas marketer Twin Eagle Holdings for $1.25 billion from Five Point Infrastructure, a deal that will help bolster the North American natural gas production giant's marketing operations.
-
July 27, 2026
DCC Energy PLC said Monday that it is backing an offer worth up to £5.75 billion ($7.7 billion) from KKR and Energy Capital Partners, making it the latest London-listed company targeted in a take-private deal by U.S. buyers.
-
July 24, 2026
Former DLA Piper partner James Manzione has returned to Gibson Dunn & Crutcher LLP as a tax partner in its New York City office.
-
July 24, 2026
Mark Cuban's Harbinger Sports Partners has taken a stake in the MLB's Athletics ahead of the former Bay Area-based team's move to Las Vegas.
-
July 24, 2026
A building products manufacturer has settled its coverage dispute with Old Republic Insurance Co., though its claims against Berkshire Hathaway Specialty Insurance Co., seeking $9.8 million in coverage for defense and settlement costs in other litigation, remain unresolved.
-
July 24, 2026
Early-stage biotechnology firm Scribe Therapeutics began trading publicly on Friday after raising $129 million in its upsized initial public offering steered by Fenwick & West LLP and Latham & Watkins LLP.